The demographics of lung cancer change every day. The disease, which directly affects the respiratory system, has long been associated with smokers—but that is rapidly changing. "Before it was rare, ...

As the rates of late-stage lung cancer in nonsmokers rise in Canada, researchers are advocating for increased awareness and screening. According to the Canadian Cancer Society, lung cancer was ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Olomorasib combined with Keytruda targets KRAS G12C-mutant NSCLC, receiving FDA Breakthrough Therapy designation for its promising efficacy in early trials. The designation is based on LOXO-RAS-20001 ...

Clara Mae Cirk, a 30-year-old who was diagnosed with stage 4 lung cancer, opens up about her journey and using social media as an outlet to educate others. Completing chemotherapy was an emotional ...

Cupertino has lost a woman who dedicated her life to the community and public service. Those close to former Mayor Hung Wei said her fighting spirit will be missed. Wei, surrounded by family and ...

Eli Lilly has won a key U.S. Food and Drug Administration designation for its investigational drug olomorasib in certain lung cancer patients. Eli Lilly on Thursday said the FDA granted ...

The Falcon Crest actress said she is "sort of on hold," but she adds, "I feel good." The Castle star's doctors have recommended quarterly infusion therapy. Susan Sullivan is doing well two years after ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has met its targeted enrollment for the NIGHTINGALE trial, which ...